NO20034322L - Behandling av demens og neurodegenerative sykdommer med intermediate doserav LHRH-antagonister - Google Patents

Behandling av demens og neurodegenerative sykdommer med intermediate doserav LHRH-antagonister

Info

Publication number
NO20034322L
NO20034322L NO20034322A NO20034322A NO20034322L NO 20034322 L NO20034322 L NO 20034322L NO 20034322 A NO20034322 A NO 20034322A NO 20034322 A NO20034322 A NO 20034322A NO 20034322 L NO20034322 L NO 20034322L
Authority
NO
Norway
Prior art keywords
dementia
treatment
neurodegenerative diseases
lhrh antagonists
intermediate doses
Prior art date
Application number
NO20034322A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034322D0 (no
Inventor
Juergen Engel
Rainer Voegeli
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of NO20034322D0 publication Critical patent/NO20034322D0/no
Publication of NO20034322L publication Critical patent/NO20034322L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
NO20034322A 2001-04-30 2003-09-26 Behandling av demens og neurodegenerative sykdommer med intermediate doserav LHRH-antagonister NO20034322L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28743401P 2001-04-30 2001-04-30
PCT/EP2002/004677 WO2002102401A1 (en) 2001-04-30 2002-04-27 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists

Publications (2)

Publication Number Publication Date
NO20034322D0 NO20034322D0 (no) 2003-09-26
NO20034322L true NO20034322L (no) 2003-09-26

Family

ID=23102886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034322A NO20034322L (no) 2001-04-30 2003-09-26 Behandling av demens og neurodegenerative sykdommer med intermediate doserav LHRH-antagonister

Country Status (28)

Country Link
US (1) US7288517B2 (bg)
EP (1) EP1392348B1 (bg)
JP (1) JP2004529207A (bg)
KR (1) KR20040000446A (bg)
CN (1) CN1317030C (bg)
AT (1) ATE400287T1 (bg)
AU (1) AU2002310788B2 (bg)
BG (1) BG108339A (bg)
BR (1) BR0209290A (bg)
CA (1) CA2444876A1 (bg)
CZ (1) CZ20033167A3 (bg)
DE (1) DE60227507D1 (bg)
DK (1) DK1392348T3 (bg)
ES (1) ES2307760T3 (bg)
HK (1) HK1072000A1 (bg)
HU (1) HUP0400067A2 (bg)
IL (1) IL156777A0 (bg)
MX (1) MXPA03008666A (bg)
NO (1) NO20034322L (bg)
NZ (1) NZ544417A (bg)
PL (1) PL362319A1 (bg)
PT (1) PT1392348E (bg)
RU (1) RU2319501C2 (bg)
SI (1) SI1392348T1 (bg)
SK (1) SK14512003A3 (bg)
UA (1) UA80679C2 (bg)
WO (1) WO2002102401A1 (bg)
ZA (1) ZA200305326B (bg)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US20020077327A1 (en) * 1999-09-23 2002-06-20 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
ES2261437T3 (es) 2000-07-05 2006-11-16 Astellas Pharma Inc. Derivados de propano-1,3-diona.
DE10137174A1 (de) * 2001-07-31 2003-02-13 Zentaris Ag Verwendung von LHRH-Antagonisten in nichtkastrierenden Dosen zur Verbesserung der T-Zellen-vermittelten Immunität
EP1752452A4 (en) * 2004-06-04 2010-07-14 Astellas Pharma Inc DERIVATIVE OF PROPANE-1, 3-DIONE OR ITS SALT
US20080171736A1 (en) * 2004-12-23 2008-07-17 Gregory Christopher W Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists
CA2590997A1 (en) * 2004-12-23 2006-07-06 Voyager Pharmaceutical Corporation Leuprolide acetate and acetylcholinesterase inhibitors or nmda receptor antagonists for the treatment of alzheimer`s disease
TW200722420A (en) * 2005-03-31 2007-06-16 Astellas Pharma Inc Propane-1,3-dion derivative or salt thereof
US8642598B2 (en) * 2006-10-21 2014-02-04 Abbvie Inc. Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
WO2009039981A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009039989A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of the peptide gly-arg-gly-asp-asn-pro as a therapeutic agent
EP2095818A1 (en) * 2008-02-29 2009-09-02 AEterna Zentaris GmbH Use of LHRH antagonists at non-castrating doses
WO2009145690A1 (en) * 2008-05-29 2009-12-03 Isr Immune System Regulation Ab Method and means for treating viral disease, in particular hiv/aids
CA2810954A1 (en) 2010-09-27 2012-04-05 Abbott Gmbh & Co. Kg Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
US9090592B2 (en) 2010-12-30 2015-07-28 AbbVie Deutschland GmbH & Co. KG Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EP3560555A1 (en) 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135743A (en) * 1960-06-29 1964-06-02 Sterling Drug Inc Steroido[2. 3-d]isoxazoles and preparation thereof
EP0901489A1 (en) * 1996-05-20 1999-03-17 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
AU767440B2 (en) * 1999-05-14 2003-11-13 Neurocrine Biosciences, Inc. Imidazo- and pyrrolo(1,2-A)pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
CA2309395A1 (en) * 1999-06-04 2000-12-04 Richard Lloyd Bowen Methods for preventing and treating alzheimer's disease
MXPA02003614A (es) 1999-10-15 2002-10-23 Neurocrine Biosciences Inc Antagonistas del receptor de la hormona liberadora de ganadotropina y metodos relacionados con los mismos..
US20030134863A1 (en) 2000-04-13 2003-07-17 Shuichi Furuya Preventives/remedies for alzheimer's disease
ES2261437T3 (es) 2000-07-05 2006-11-16 Astellas Pharma Inc. Derivados de propano-1,3-diona.

Also Published As

Publication number Publication date
NZ544417A (en) 2008-03-28
SK14512003A3 (sk) 2004-08-03
CZ20033167A3 (cs) 2004-08-18
JP2004529207A (ja) 2004-09-24
SI1392348T1 (sl) 2008-12-31
RU2319501C2 (ru) 2008-03-20
CN1575185A (zh) 2005-02-02
IL156777A0 (en) 2004-02-08
HUP0400067A2 (hu) 2004-04-28
BG108339A (bg) 2004-11-30
BR0209290A (pt) 2004-07-13
ZA200305326B (en) 2003-07-30
EP1392348B1 (en) 2008-07-09
DK1392348T3 (da) 2008-09-29
RU2003134949A (ru) 2005-02-10
KR20040000446A (ko) 2004-01-03
HK1072000A1 (en) 2005-08-12
UA80679C2 (en) 2007-10-25
CN1317030C (zh) 2007-05-23
NO20034322D0 (no) 2003-09-26
CA2444876A1 (en) 2002-12-27
ES2307760T3 (es) 2008-12-01
MXPA03008666A (es) 2004-10-15
PL362319A1 (en) 2004-10-18
DE60227507D1 (de) 2008-08-21
PT1392348E (pt) 2008-09-09
AU2002310788B2 (en) 2007-04-05
US7288517B2 (en) 2007-10-30
WO2002102401A1 (en) 2002-12-27
US20020177556A1 (en) 2002-11-28
EP1392348A1 (en) 2004-03-03
ATE400287T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
HK1072000A1 (en) Treatment of alzheimer's diseases with intemediatedoses of lhrh antagonists
LU92854I2 (fr) Combinaison de rilpivirine ou une forme thérapeutique équivalente qui en dérive telle que protégé par le brevet de base, tel qu'un sel pharmaceutiquement acceptable de rilpivirine, incluant le sel chlorhydrate de rilpivirine, et ténofovir, en particulier le fumarate de ténofovir disoproxil
TR200001608T2 (tr) Amiloidojenik hastalığın önlenmesi ve tedavisi
LTPA2015001I1 (lt) Tioflavino dariniai ir jų panaudojimas Alzhaimerio ligos diagnostikai ir terapijai
NO20022531D0 (no) Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer
GB0223040D0 (en) Therapeutic compounds
EA200800880A1 (ru) Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции
DE69533174D1 (de) Pyridopyrimidinone, chinoline und anellierte n-heterozyklen als bradykinin-antagonisten
WO2002002506A3 (en) Compounds to treat alzheimer's disease
EE200200716A (et) Ühendid Alzheimeri tõve käitluseks
EA200400352A1 (ru) Органолептически приемлемые распадающиеся во рту композиции
TNSN04165A1 (en) Substituted hydroxyethylamines
DE60144514D1 (de) Verwendung von il-18 inhibitoren
JO2207B1 (en) Pharmaceutical radiological compounds to diagnose Alzheimer's disease
NO20053341D0 (no) Hindring og behandling av Alzheimers sykdom.
NO20000771L (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
DE60028928D1 (de) Verwendung von angiotensin ii rezeptorantagonisten zur behandlung von akutem myokardischen infarkt
HUP0400528A2 (hu) Neuropeptidáz Y inhibitor alkalmazása férfiak szexuális funkciózavarának kezelésére alkalmas gyógyszerkészítmény előállítására
SE0002353D0 (sv) New use
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.
YU9099A (en) Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producting a pharmaceutical preparation for treatment of the alzheimer's disease
AU2002319451A1 (en) Therapeutic strategies for prevention and treatment of alzheimer's disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application